Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Steinberg

Showing results (1021-1030 of 1,520) with videos related to

Pageof 152
Sort By:
Cancers|February 24, 2024
Pulmonary Metastasectomy for Adrenocortical Carcinoma-Not If, but WhenShamus R Carr, Frank Villa Hernandez, Diana Grace Varghese, et al.
Journal of the American Medical Informatics Association : JAMIA|February 26, 2016
Mobile health devices: will patients actually use them?Ryan J Shaw, Dori M Steinberg, Jonathan Bonnet, et al.
The Journal of Urology|April 12, 2005
A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapyJames L Gulley, William D Figg, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 1992
Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer InstituteA S Lichter, M E Lippman, D N Danforth, et al.
Radiology|June 1, 1988
Lumbar spine: postoperative MR imaging with Gd-DTPAM G Hueftle, M T Modic, J S Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancerM A Rudek, W D Figg, V Dyer, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1994
Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytesD J Cole, J K Taubenberger, B A Pockaj, et al.
The Pharmacogenomics Journal|December 30, 2009
A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platformJ F Deeken, T Cormier, D K Price, et al.
Oncotarget|June 2, 2015
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosisAnish Thomas, Yuanbin Chen, Seth M Steinberg, et al.
Surgery|December 1, 1992
A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreasJ R Lange, S M Steinberg, G M Doherty, et al.
Pageof 152

Showing results (1021-1030 of 1,520) with videos related to

Sort By:
Pageof 152
Cancers|February 24, 2024
Pulmonary Metastasectomy for Adrenocortical Carcinoma-Not If, but WhenShamus R Carr, Frank Villa Hernandez, Diana Grace Varghese, et al.
Journal of the American Medical Informatics Association : JAMIA|February 26, 2016
Mobile health devices: will patients actually use them?Ryan J Shaw, Dori M Steinberg, Jonathan Bonnet, et al.
The Journal of Urology|April 12, 2005
A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapyJames L Gulley, William D Figg, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 1992
Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer InstituteA S Lichter, M E Lippman, D N Danforth, et al.
Radiology|June 1, 1988
Lumbar spine: postoperative MR imaging with Gd-DTPAM G Hueftle, M T Modic, J S Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancerM A Rudek, W D Figg, V Dyer, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1994
Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytesD J Cole, J K Taubenberger, B A Pockaj, et al.
The Pharmacogenomics Journal|December 30, 2009
A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platformJ F Deeken, T Cormier, D K Price, et al.
Oncotarget|June 2, 2015
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosisAnish Thomas, Yuanbin Chen, Seth M Steinberg, et al.
Surgery|December 1, 1992
A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreasJ R Lange, S M Steinberg, G M Doherty, et al.
Pageof 152